315 related articles for article (PubMed ID: 25694157)
21. Antifolate resistance associated point mutations among asymptomatic malaria cases.
Sharma J; Dutta P; Khan SA
J Vector Borne Dis; 2016 Mar; 53(1):81-3. PubMed ID: 27004583
[No Abstract] [Full Text] [Related]
22. Why has the dihydrofolate reductase 164 mutation not consistently been found in Africa yet?
Nzila A; Ochong E; Nduati E; Gilbert K; Winstanley P; Ward S; Marsh K
Trans R Soc Trop Med Hyg; 2005 May; 99(5):341-6. PubMed ID: 15780340
[TBL] [Abstract][Full Text] [Related]
23. Direct evidence that asparagine at position 108 of the Plasmodium falciparum dihydrofolate reductase is involved in resistance to antifolate drugs in Tanzania.
Curtis J; Duraisingh MT; Trigg JK; Mbwana H; Warhurst DC; Curtis CF
Trans R Soc Trop Med Hyg; 1996; 90(6):678-80. PubMed ID: 9015515
[TBL] [Abstract][Full Text] [Related]
24. Evolution of resistance to sulfadoxine-pyrimethamine in Plasmodium falciparum.
Gatton ML; Martin LB; Cheng Q
Antimicrob Agents Chemother; 2004 Jun; 48(6):2116-23. PubMed ID: 15155209
[TBL] [Abstract][Full Text] [Related]
25. Resistance to antifolates in Plasmodium falciparum, the causative agent of tropical malaria.
Warhurst DC
Sci Prog; 2002; 85(Pt 1):89-111. PubMed ID: 11969121
[TBL] [Abstract][Full Text] [Related]
26. Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.
Schönfeld M; Barreto Miranda I; Schunk M; Maduhu I; Maboko L; Hoelscher M; Berens-Riha N; Kitua A; Löscher T
Malar J; 2007 Jan; 6():2. PubMed ID: 17224049
[TBL] [Abstract][Full Text] [Related]
27. Use of a semi-nested PCR diagnosis test to evaluate antifolate resistance of Plasmodium falciparum isolates.
Eldin de Pecoulas P; Abdallah B; Dje MK; Basco LK; le Bras J; Mazabraud A
Mol Cell Probes; 1995 Dec; 9(6):391-7. PubMed ID: 8808309
[TBL] [Abstract][Full Text] [Related]
28. Rapid genotyping of loci involved in antifolate drug resistance in Plasmodium falciparum by primer extension.
Nair S; Brockman A; Paiphun L; Nosten F; Anderson TJ
Int J Parasitol; 2002 Jun; 32(7):852-8. PubMed ID: 12062556
[TBL] [Abstract][Full Text] [Related]
29. Surveillance of antifolate-resistant malaria.
Basco LK; Tahar R; Ringwald P
Lancet; 1998 Aug; 352(9125):406. PubMed ID: 9717957
[No Abstract] [Full Text] [Related]
30. Transgenic pyrimethamine-resistant plasmodium falciparum reveals transmission-blocking potency of P218, a novel antifolate candidate drug.
Posayapisit N; Pengon J; Prommana P; Shoram M; Yuthavong Y; Uthaipibull C; Kamchonwongpaisan S; Jupatanakul N
Int J Parasitol; 2021 Jul; 51(8):635-642. PubMed ID: 33713651
[TBL] [Abstract][Full Text] [Related]
31. Increasing prevalence of wildtypes in the dihydrofolate reductase gene of Plasmodium falciparum in an area with high levels of sulfadoxine/pyrimethamine resistance after introduction of treated bed nets.
Alifrangis M; Lemnge MM; Rønn AM; Segeja MD; Magesa SM; Khalil IF; Bygbjerg IC
Am J Trop Med Hyg; 2003 Sep; 69(3):238-43. PubMed ID: 14628937
[TBL] [Abstract][Full Text] [Related]
32. Emergence of an unusual sulfadoxine-pyrimethamine resistance pattern and a novel K540N mutation in dihydropteroate synthetase in Plasmodium falciparum isolates obtained from Car Nicobar Island, India, after the 2004 Tsunami.
Lumb V; Das MK; Mittra P; Ahmed A; Kumar M; Kaur P; Dash AP; Singh SS; Sharma YD
J Infect Dis; 2009 Apr; 199(7):1064-73. PubMed ID: 19220141
[TBL] [Abstract][Full Text] [Related]
33. Sulfadoxine-pyrimethamine resistance in Plasmodium falciparum: a zoomed image at the molecular level within a geographic context.
Abdul-Ghani R; Farag HF; Allam AF
Acta Trop; 2013 Feb; 125(2):163-90. PubMed ID: 23131424
[TBL] [Abstract][Full Text] [Related]
34. Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine-pyrimethamine in Sri Lanka.
Hapuarachchi HC; Dayanath MY; Bandara KB; Abeysundara S; Abeyewickreme W; de Silva NR; Hunt SY; Sibley CH
Am J Trop Med Hyg; 2006 Feb; 74(2):198-204. PubMed ID: 16474070
[TBL] [Abstract][Full Text] [Related]
35. Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate Pyrimethamine/Sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum.
Nzila AM; Nduati E; Mberu EK; Hopkins Sibley C; Monks SA; Winstanley PA; Watkins WM
J Infect Dis; 2000 Jun; 181(6):2023-8. PubMed ID: 10837185
[TBL] [Abstract][Full Text] [Related]
36. Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine.
Iyer JK; Milhous WK; Cortese JF; Kublin JG; Plowe CV
Lancet; 2001 Sep; 358(9287):1066-7. PubMed ID: 11589941
[TBL] [Abstract][Full Text] [Related]
37. Malaria: use of restriction endonuclease digestion and mutation-specific PCR for antifolate resistance isolate detection.
Kengne P; Ouédraogo JB; Zampan H; Veas F; Guiguemdé TR
Parassitologia; 2003 Mar; 45(1):27-31. PubMed ID: 15270541
[TBL] [Abstract][Full Text] [Related]
38. High prevalence of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville, Republic of Congo.
Koukouikila-Koussounda F; Bakoua D; Fesser A; Nkombo M; Vouvoungui C; Ntoumi F
Infect Genet Evol; 2015 Jul; 33():32-6. PubMed ID: 25934142
[TBL] [Abstract][Full Text] [Related]
39. Novel alleles of Plasmodium falciparum dhfr that confer resistance to chlorcycloguanil.
Hunt SY; Rezvani BB; Sibley CH
Mol Biochem Parasitol; 2005 Jan; 139(1):25-32. PubMed ID: 15610816
[TBL] [Abstract][Full Text] [Related]
40. Origin of robustness in generating drug-resistant malaria parasites.
Kümpornsin K; Modchang C; Heinberg A; Ekland EH; Jirawatcharadech P; Chobson P; Suwanakitti N; Chaotheing S; Wilairat P; Deitsch KW; Kamchonwongpaisan S; Fidock DA; Kirkman LA; Yuthavong Y; Chookajorn T
Mol Biol Evol; 2014 Jul; 31(7):1649-60. PubMed ID: 24739308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
